Gadoquatrane
Small Molecule
Overview
Gadoquatrane is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL6068450).
Patent & exclusivity (US)
Per the FDA Orange Book (6 approved US products), the latest listed US patent on Gadoquatrane expires — and exclusivity 12 Jun 2031. Generic API sourcing typically opens up once these lapse.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.